Assessment of the specificity of a commercial human parvovirus B19 IgM assay

Clinical and Diagnostic Virology

Volumn 7, Issue 3, 1997, Pages 133-137

  Jensen, Inge Panum ^a   Vestergaard, Bent Faber ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Human parvovirus B19; IgM; Specificity

Indexed keywords

IMMUNOGLOBULIN M;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DENMARK; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PARVOVIRUS; PRIORITY JOURNAL; RUBELLA VIRUS; SEROLOGY; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN M; MEASLES VIRUS; PARVOVIRUS B19, HUMAN; RUBELLA VIRUS; SEROLOGIC TESTS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; MEASLES VIRUS; PARVOVIRUS; RUBELLA VIRUS;

EID: 0031080301     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(96)00262-0     Document Type: Article

References (16)

1. Anderson, M.J., Higgins, P.G., Davis, L.R., Williman, J.S., Jones, S.E., Kidd, I.M., Pattison, J.R. and Tyrrell, D.A.J. (1985) Experimental parvoviral infection in humans. J. Infect. Dis., 152, 257-264.
2. Anderson, M.J., Kidd, I.M. and Morgan-Capner, P (1985) Human parvovirus and rubella-like illness. Lancet, 2, 663.
3. Anderson, M.J. (1987) Human parvovirus infections. J. Virol. Methods, 17, 175-181.
4. Chernak, E., Dubin, G., Henry, D., Naides, S.J., Hodinka, R.L., MacGregor, R.R. and Friedman, H.M. (1995) Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. J. Clin. Infect. Dis., 20, 170-173.
5. Cohen, B.J. and Shirley, J.A. (1985) Dual infection with rubella and human parvovirus. Lancet, 2, 662-663.
6. Cohen, B.J. and Supran, E.M. (1987) IgM serology for rubella and human parvovirus B19. Lancet, 1, 393.
7. Cohen, B.J. and Bates, C.M. (1995) Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J. Virol. Methods, 55, 11-25.
8. Henle, G. and Henle, W. (1979) The virus as etiologic agent of infectious mononucleosis. In: M.A. Epstein and B.C. Achong (Eds.), The Epstein-Barr Virus, Springer-Verlag, Berlin, pp. 297-320.
9. Høier-Madsen, M., Nielsen, L.P. and Møller, S. (1986). Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr. Læger, 148, 2018-2021.
10. Kerr, J.R. (1996) Parvovirus B19 infection. Eur. J. Clin. Microbiol. Infect. Dis., 15, 10-29.
11. Kurtz, J.B. and Anderson, M.J. (1985) Cross-reactions in rubella and parvovirus specific IgM tests. Lancet, 2, 1356.
12. Lefrere, J.J., Bricout, F., Bertrand, Y., Nicholas, J.C. and Courouge, A.M. (1987) Human parvovirus and rubella cross-reactions in specific IgM tests. Lancet, 1, 50.
13. Nielsen, C.M., Hansen, K., Andersen, H.M.K., Gerstoft, J. and Vestergaard, B.F. (1987) An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM anti-bodies in human serum: Specific and non-specific reactions. J. Med. Virol., 22, 67-76.
14. Rode Pedersen, I., Antonsdottir, A., Evald, T. and Mordhorst, C.H. (1982) Detection of measles IgM by enzyme-linked immunosorbent assay (ELISA). Acta Pathol. Microbiol. Immunol. Scand. Sect. B., 90, 153-160.
15. Public Health Laboratory Service Working Party on Fifth Disease (1990) Prospective study of human parvovirus (B19) infection in pregnancy. Br. Med. J, 300, 1166-1170.
16. Vejtorp, M. (1981) Solid phase anti-IgM ELISA for detection of rubella specific IgM antibodies. Acta Pathol. Microbiol. Scan. Sec. B., 89, 123-128.